GLP-1 Drugs Linked to 31% Lower Diabetes Risk Than Metformin in Prediabetes

GLP-1 drugs were linked to a 31% lower type 2 diabetes risk than metformin in 256,492 adults with prediabetes, a Mayo Clinic analysis finds.